3SBio is a biotechnology company that is focused on researching, developing, manufacturing, and marketing. The firm was founded in 1993 in Shenyang, Liaoning, China.
The firm is interested in markets such as nephrology, oncology, supportive cancer care, infectious diseases, and inflammation. The firm is interested in acquiring companies such as Therapure Biopharma, Zhejiang Wansheng Pharmaceutical, and Sirton Pharmaceuticals. The firm has investment interests in industries of gene-therapy, biotechnology, immunotherapy, and genetic engineering.